Pulmonary Fibrosis News

An experimental therapy, brilaroxazine showed a treatment potential in models of idiopathic pulmonary fibrosis and pulmonary hypertension. https://buff.ly/3yDhCfz

Getting to know people outside their health journeys was rewarding for columnist Sam Kirton, who likes to discover shared experiences. https://buff.ly/3YIlXsl

Brainomix is partnering with Boehringer Ingelheim to bring its AI-powered imaging tool, e-Lung, for PF diagnosis to U.S. pulmonology centers. https://buff.ly/4ck00mv

Managing a rare disease comes with high costs, says columnist Charlene Marshall, who had to stop taking a medication because of its price. https://buff.ly/3M47orr

Columnist Sam Kirton describes necessary precautions for IPF and post-transplant patients during times of increasingly rising temperatures. https://buff.ly/46DS8eI

Enrollment has been completed for a Phase 2a study testing IPF treatment BBT-877, Bridge Biotherapeutics' investigational therapy. https://buff.ly/4fu29yU

Four years after her mother's death, columnist Ann Reynoso works through the lingering grief in a "Dear Mom" letter. https://buff.ly/4d3uSsJ

Columnist Sam Kirton asks his PF community to support the SOAR Act, which aims to improve patient access to supplemental oxygen. https://buff.ly/4c5zFIZ

Enrollment for the Phase 3 TETON 2 trial testing Tyvaso in adults with IPF is complete, with data expected in 2025. https://buff.ly/3Yqcead

While columnist Sam Kirton's quality of life improved after his lung transplant, the healing journey hasn't been easy, he says. https://buff.ly/4cY5K6U

UW-Madison researchers have been granted nearly $11 million to explore mechanisms that drive idiopathic pulmonary fibrosis progression. https://buff.ly/4daBC7F

Columnist Sam Kirton remembers getting his new lungs and doing his exercises during his first 10 days of transplant recovery. https://buff.ly/3zSho4d

Phase 2a trials of oral IPF treatment candidate INS018_055 are moving forward in the U.S. and China, with a Phase 2b study planned for 2025. https://buff.ly/3xL6TiO

In honor of his lung transplant anniversary, columnist Sam Kirton pays tribute to his donor and raises awareness about organ donation. https://buff.ly/3VP2Ppq

Growing older and living with pulmonary fibrosis means some heavy physical and emotional consequences to analyze, says columnist Ann Reynoso. https://buff.ly/4cIibmH

Getting your affairs in order benefits both you and your loved ones, says columnist Sam Kirton, who took action after his IPF diagnosis. https://buff.ly/4boz3xz

A tracer known as FAPI performed better than the commonly used 18F-FDG for capturing early signs of pulmonary fibrosis on PET/CT scans. https://buff.ly/45NqSKk

After spending a week with his young granddaughters, columnist Sam Kirton gives thanks for the transplant that granted him the opportunity. https://buff.ly/4bh6emU

AGMB-447, an inhaled IPF treatment being tested in a Phase 1 clinical trial, has been granted FDA orphan drug designation by the FDA. https://buff.ly/3RCVhVQ

Columnist Charlene Marshall shares her tips for how to deal with guilt from having a chronic lung disease, particularly while traveling. https://buff.ly/3zb6S86

In preparation for a visit with his granddaughters, columnist Sam Kirton works on childproofing his home to make it safe for everyone. https://buff.ly/3KQmhNM

The FDA has granted its orphan drug designation to Alentis Therapeutics’ lixudebart (ALE.F02) for idiopathic pulmonary fibrosis. https://buff.ly/3x95YZc

ENV-101 improved lung function and reversed key signs of lung scarring in patients with IPF, according to data from a Phase 2a trial. https://buff.ly/3RFRNSv

Despite her IPF, columnist Charlene Marshall has found these weight loss strategies to be accessible and effective. https://buff.ly/3x9b8UT

Deciding whether to pursue a lung transplant for idiopathic pulmonary fibrosis is a complex and personal decision, says columnist Sam Kirton. https://buff.ly/45qjJPX

The PF Foundation's Community Registry, a database of patient and family member information, logged its 2,000th participant. https://buff.ly/4bHrFOM

Columnist Sam Kirton explains what an acute exacerbation of IPF can look like, and why urgent action is needed. https://buff.ly/44WQwf7

In the U.K., people with idiopathic pulmonary fibrosis who live in economically deprived areas tend to have worse survival outcomes, a study finds. https://buff.ly/3WTFpS0

Columnist Sam Kirton encourages his readers to check out the forums, news articles, and other columns on Pulmonary Fibrosis News. https://buff.ly/3wRzNwX

Once-daily bexotegrast reversed the signs of lung scarring while improving lung function and cough in IPF patients, an imaging study finds. https://buff.ly/3wFILxg